412 results
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in BRS/BVS:
- Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
- France Absorb registry: final five years follow-up
- A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
- Three-year follow-up of the prospective bvs stemi strategy-it study
- Final five-year results of AIDA trial
- Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in drugs & devices:
- POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
- CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
- PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
Managing a patient with STEMI and bystander disease in the pandemic (Part 2) - Session with LIVE case
20 May 2021 – From EuroPCR 2021
Watch this session if you want to be updated on developments in treatment of ACS and STEMI, and to discuss diagnosis and treatment for bystander disease.
This session was originally presented during EuroPCR 2021.
Managing a patient with STEMI and bystander disease in the pandemic (Part 1) - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to be updated on developments in treatment of ACS and STEMI and to discuss diagnosis and treatment for bystander disease.
This session was originally presented during EuroPCR 2021.
EuroIntervention - Most discussed papers of the year
19 May 2021 – From EuroPCR 2021
Watch this session if you want to know the top 3 most discussed papers of the year which concern management of myocardial revascularisation failure, the impact of COVID-19 pandemic on interventional cardiology practice and Ischaemia witch non-obstructive coronary arteries.
This session was originally presented during EuroPCR 2021.
Importance of extensive revascularisation and timing of mechanical circulatory support
19 May 2021 – From EuroPCR 2021
Watch this session presented by Carsten Tschöpe, Francesco Burzotta and Nikos Werner in order to learn and see real-world revascularisation strategies with mechanical circulatory support, and to know more about the importance of extensive revascularisation and of the timing of mechanical circulatory support in high-risk interventions and cardiogenic shock.
Coronary physiology in STEMI: is OpSens OptoWire III a game-changer in complete revascularisation?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Thomas Engstrom, Zsolt Piroth, Jacques Monsegu and Giuseppe Biondi-Zoccai in order to get an update on the latest evidence in physiology-guided full revascularisation in STEMI patients, to discover how the innovative physiology wire, OptoWire III from OpSens may lower the barriers to approach...
LM trifurcation STEMI
18 May 2021 – From EuroPCR 2021
Watch the case of this 69-year-old male patient suffering from LM trifurcation with sub-occlusive lesion who presented with severe bradycardia and hypotension after angios: would you have treated him the same way?
Dealing with shock
18 May 2021 – From EuroPCR 2021
Find out more about left main shock syndrome, always an unpredictable situation, and study the case of a STEMI patient with cardiogenic shock.
Acute STEMI, coronary ectasia and large thrombus burden
18 May 2021 – From EuroPCR 2021
In this session, discover why the combination of DOAC's and DAPT have promising role in the management of large thrombus and coronary ectasia.
